Published in J Am Soc Nephrol on March 01, 2001
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50
Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study. BMJ (2015) 2.11
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol (2009) 1.69
Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant (2010) 1.65
Organ donation decision: comparison of donor and nondonor families. Am J Transplant (2006) 1.58
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.26
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
A decade of experience with renal transplantation in African-Americans. Ann Surg (2002) 1.06
Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors. Clin J Am Soc Nephrol (2015) 1.05
Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg (2004) 1.04
Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant (2010) 1.01
Deceased donor renal transplantation at army hospital research and referral: Our experience. Indian J Urol (2013) 1.01
Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med (2014) 0.98
Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol (2012) 0.98
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant (2008) 0.96
Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol (2014) 0.94
Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use. Am J Transplant (2009) 0.94
Trends in the inactive kidney transplant waitlist and implications for candidate survival. Am J Transplant (2013) 0.93
Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? Ann Surg (2006) 0.90
Outcomes of kidney transplantation in Greek and Albanian patients: a single centre experience. Hippokratia (2008) 0.88
Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution. World J Urol (2012) 0.87
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study. Am J Transplant (2016) 0.82
Survival Benefit of Kidney Transplantation in HIV-infected Patients. Ann Surg (2016) 0.81
Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol (2008) 0.81
Use of marginal organs in kidney transplantation for marginal recipients: too close to the margins of safety? Eur J Med Res (2010) 0.81
Marginal kidney donor. Indian J Urol (2007) 0.79
Renal transplantation with expanded criteria donors: Which is the optimal immunosuppression? World J Transplant (2016) 0.78
Hypothermic machine perfusion reduces delayed graft function and improves one-year graft survival of kidneys from expanded criteria donors: a meta-analysis. PLoS One (2013) 0.78
Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors. Transplantation (2011) 0.78
Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. Transplantation (2014) 0.77
National outcomes of kidney transplantation from deceased diabetic donors. Kidney Int (2015) 0.77
Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation. Curr Cardiol Rev (2009) 0.77
Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors. PLoS One (2015) 0.77
Persufflation (gaseous oxygen perfusion) as a method of heart preservation. J Cardiothorac Surg (2013) 0.77
Robotic kidney transplantation: one year after the beginning. World J Urol (2017) 0.77
Impact of obesity on urologic complications among unrelated living donor kidney transplants. Indian J Surg (2010) 0.76
Reuse of a previously transplanted kidney: does success come with a price? Clin Kidney J (2012) 0.76
Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant. Am J Transplant (2016) 0.76
A Nationwide Assessment of the Burden of Urinary Tract Infection among Renal Transplant Recipients. J Transplant (2015) 0.76
Geographic Variation in Cold Ischemia Time: Kidney vs. Liver Transplantation in the United States, 2003-2011. Transplant Direct (2015) 0.75
Donor Heart Utilization following Cardiopulmonary Arrest and Resuscitation: Influence of Donor Characteristics and Wait Times in Transplant Regions. J Transplant (2014) 0.75
Focus group study of public opinion about paying living kidney donors in Australia. Clin J Am Soc Nephrol (2015) 0.75
Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies. World J Transplant (2014) 0.75
Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age. Clin J Am Soc Nephrol (2016) 0.75
Can cardiac troponin T level be used to predict survival of patients awaiting renal transplantation? Nat Clin Pract Nephrol (2009) 0.75
Transplantation: The vexing challenges of deceased donor organ allocation. Nat Rev Nephrol (2015) 0.75
Rupture of renal transplant. Case Rep Transplant (2015) 0.75
Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death. Clin J Am Soc Nephrol (2015) 0.75
Trends in Usage and Outcomes for Expanded Criteria Donor Kidney Transplantation in the United States Characterized by Kidney Donor Profile Index. Cureus (2016) 0.75
Predictive Score for Posttransplantation Outcomes. Transplantation (2016) 0.75
Suggestions on how to make suboptimal kidney transplantation an ethically viable option. Open Med (Wars) (2016) 0.75
Considering potential benefits and consequences of hospital report cards: what are the next steps? Health Serv Res (2015) 0.75
Enhancing the expanded criteria donor policy as an intervention to improve kidney allocation: is it actually a 'net-zero' model? Am J Transplant (2010) 0.75
Transplantation: pediatric en bloc kidneys are suitable for adult recipients. Nat Rev Nephrol (2010) 0.75
Might the current gauge of transplant center quality result in reducing patient access via diminished organ utilization? Clin J Am Soc Nephrol (2014) 0.75
The Canadian experience using the expanded criteria donor classification for allocating deceased donor kidneys for transplantation. Can J Kidney Health Dis (2016) 0.75
Is an 87-Year-Old Grandfather Too Marginal for Being a Kidney Donor? The View of Anesthesiologists. J Clin Med Res (2016) 0.75
Advances in the Knowledge about Kidney Decellularization and Repopulation. Front Bioeng Biotechnol (2017) 0.75
Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation. J Am Heart Assoc (2017) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc (2001) 3.90
Development and acceptance of medical information systems: an historical overview. J Health Hum Resour Adm (1988) 3.76
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA (1993) 3.10
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Median sensory distal amplitude and latency: comparisons between nonexposed managerial/professional employees and industrial workers. Am J Ind Med (1993) 2.87
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther (1997) 2.17
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab (1989) 2.03
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results. Chest (1993) 1.89
Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care (1999) 1.82
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve (1992) 1.80
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant (2008) 1.73
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Use of community versus individual socioeconomic data in predicting variation in hospital use. Health Serv Res (1998) 1.64
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Preimplantation diagnosis of single gene disorders by two-step oocyte genetic analysis using first and second polar body. Biochem Mol Med (1997) 1.52
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Lies, damn lies, and statistics: the perils of the P value. Am J Transplant (2006) 1.50
Primum non Nocere: is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transplant (2009) 1.49
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
Transvaginal ultrasound in patients with low beta-human chorionic gonadotropin values: how often is the study diagnostic? Ann Emerg Med (1997) 1.47
Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant (2006) 1.47